long term effects of glp-1 agonists The expanding role receptor agonists: a narrative review of current evidence and future directions The cardiovascular effects of GLP-1

Employee of AstraZeneca (R.C.L., K.M., S.O., J.C., J.N., J.G., L.J., C.J.R.)

By alleviating chronic systemic inflammation, GLP-1RAs may help prevent the progression of HF and adverse cardiovascular events

At Blue Haven Rx, we understand how deeply weight and metabolic health are connected

Lixisenatide in patients with type 2 diabetes and Acute Coronary Syndrome

doi: 10.1016/j.jpba.2021.113921 [DOI] [PubMed] [Google Scholar] 124.Calvarysky B, Dotan I, Shepshelovich D, Leader A, Cohen TD

Biosimilar semaglutide development is advancing toward regulatory review by multiple pharmaceutical companies, with FDA biosimilar pathways potentially enabling lower-cost GLP-1 access within the forecast period